Sobre la alergia
Preguntas frecuentes
Actualidad
Información práctica
Sobre esta web
 
 
 
Información práctica/Artículos de interés

-. ArtÍculos de interÉs


1.- Armisén M, Guspi R, Alfaya T, et al. Cross-Sectional Validation of a Quality of Life Questionnaire in Spanish for Patients Allergic to Hymenoptera Venom. J Investig Allergol Clin Immunol. 2015;25(3):176-82.

https://www.ncbi.nlm.nih.gov/pubmed/26182683

2.- Alfaya T, Vega A, Domínguez-Noche C, Ruiz B, Marqués L, Sánchez-Morillas L. Longitudinal Validation of the Spanish Version of the Health-Related Quality of Life Questionnaire for Hymenoptera Venom Allergy (HRQLHA). J Investig Allergol Clin Immunol. 2015;25(6):426-30.

https://www.ncbi.nlm.nih.gov/pubmed/26817139

3.- Gutiérrez Fernández D, Moreno-Ancillo A, Fernández Meléndez S, et al. Insect Venom Immunotherapy: Analysis of the Safety and Tolerance of 3 Buildup Protocols Frequently Used in Spain. J Investig Allergol Clin Immunol. 2016;26(6):366-373. 

https://www.ncbi.nlm.nih.gov/pubmed/27996943

4.- Ruiz B, Serrano P, Moreno C. IgE-Api m 4 Is Useful for Identifying a Particular Phenotype of Bee Venom Allergy. J Investig Allergol Clin Immunol. 2016;26(6):355-361.

https://www.ncbi.nlm.nih.gov/pubmed/27996941

5.- Bilo BM, Rueff F, Mosbech H, Bonifazi F, Oude-Elberink JN. Diagnosis of Hymenoptera venom allergy. Allergy. 2005;60(11):1339-1349.

http://www.ncbi.nlm.nih.gov/pubmed/16197464

6.- Bonifazi F, Jutel M, Biló BM, Birnbaum J, Muller U. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy. 2005;60:1459-70.

http://www.ncbi.nlm.nih.gov/pubmed/16266376

7.- Monsalve RI, Vega A, Marques L, et al. Component-resolved diagnosis of vespid venom-allergic individuals: phospholipases and antigen 5s are necessary to identify Vespula or Polistes sensitization. Allergy. 67(4):528-536.

http://www.ncbi.nlm.nih.gov/pubmed/22229815.

8.- Rueff F, Przybilla B, Bilo MB, et al. Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase. J Allergy Clin Immunol. 2010;126(1):105-11 e5.

http://www.ncbi.nlm.nih.gov/pubmed/20542320

9.- Ruëff F, Przybilla B, Biló MB, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol. 2009;124(5):1047-54.

http://www.ncbi.nlm.nih.gov/pubmed/19895993

10.- Marques L, Vega A, Munoz E, Moreno-Ancillo A. Epidemiologic observations on Hymenoptera allergy in Spain: the Alergologica-2005 study. J Investig Allergol Clin Immunol. 2009;19 Suppl 2:51-55.

http://www.ncbi.nlm.nih.gov/pubmed/19530419

11.- Golden DB. Advances in diagnosis and management of insect sting allergy. Ann Allergy Asthma Immunol. 2013;111:84-89.

http://www.ncbi.nlm.nih.gov/pubmed/23886224

12.- Armisén M, Guspi R, Alfaya T, Cruz S, Fernández S, Domínguez-Noche C, Alonso A, Gaspar D, Marqués L, Vega A. Cross-Sectional Validation of a Quality of Life Questionnaire in Spanish for Patients Allergic to Hymenoptera Venom. J Investig Allergol Clin Immunol. 2015 Jan;25(3):176–82.

http://www.ncbi.nlm.nih.gov/pubmed/26182683

13.- Köhler J, Blank S, Müller S, Bantleon F, Frick M, Huss-Marp J, et al. Component resolution reveals additional major allergens in patients with honeybee venom allergy. J Allergy Clin Immunol. 2014 May;133:1383–9.

http://www.ncbi.nlm.nih.gov/pubmed/24440283

14.- Ruiz B, Serrano P, Verdú M, Moreno C. Sensitization to Api m 1, Api m 2, and Api m 4: association with safety of bee venom immunotherapy. Ann Allergy Asthma Immunol. 2015 Feb 27;114(4):350–2.

http://www.ncbi.nlm.nih.gov/pubmed/25736542



Copyright ® 2016 Alk Abelló. Todos los derechos reservados. Estratagema Healthcare